Valiant Laboratories Limited Rights Issue 2025 FAQ's

₹81.47 Crores | Listing at BSE, NSE | Mon, Jul 28, 2025 - Fri, Aug 8, 2025

Valiant Laboratories Limited Rights Issue Date 2026 & Price FAQs

The timetable for Valiant Laboratories Limited Rights Issue is as follows:

Last Date for credit of Rights EntitlementsMon, Jul 21, 2025
Last Date for renunciation of Rights EntitlementsTue, Aug 5, 2025
Issue Opening DateMon, Jul 28, 2025
Issue Closing DateFri, Aug 8, 2025
Date of Allotment (on or about)Mon, Aug 11, 2025
Date of Credit (on or about)Tue, Aug 12, 2025
Date of Listing (on or about)Wed, Aug 13, 2025

Valiant Laboratories Limited Rights Issue 2025 price is set at ₹75 per share. The Valiant Laboratories Limited Rights Issue 2025 opens on Mon, Jul 28, 2025, and closes on Fri, Aug 8, 2025, for the subscription.

The allotment of Valiant Laboratories Limited Rights Issue 2025 is expected to happen on or about August 11, 2025 as per the issue schedule.

Valiant Laboratories Limited Rights Issue 2025 is expected to list on or around August 13, 2025.

The credit of Valiant Laboratories Limited Rights Issue 2025 in Demat account is expected on or about August 12, 2025 as per the issue schedule.

Objects of the Issue:

The intend to utilise the gross proceeds raised through the Issue (the “Issue Proceeds”) after deducting the Issue-related expenses (“Net Proceeds”) for the below-mentioned Objects (collectively, referred to as the “Objects”):

  1. Adjustment of Unsecured Loans of Promoter/Promoter Group towards Rights Equity Shares Application Money;
  2. Repayment of outstanding loans of existing promoters Dhanvallabh Ventures LLP;
  3. Capital Expenditure; and
  4. General Corporate Purposes

It is difficult to predict the exact listing price of Valiant Laboratories Limited Rights Issue shares. The price depends on the demand and supply of the company's shares on the day of listing.

We do not provide Rights Issue recommendations. However, we share a lot of information about Valiant Laboratories Limited which could help you with questions like whether to subscribe or not. Consider reading Valiant Laboratories Limited reviews and analysis from experts posted on the Rights Issue detail page.